COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,306 Articles (22,772 medRxiv, 8,534 bioRxiv)

Most recent first Previous |  Page 40: Articles 391-400  | Next

Economic crisis and post-COVID adaptations in Directly Observed Therapy practices among tuberculosis patients in Colombo, Sri Lanka: A cross-sectional study
Alahakoon, T., Jayaweera, R., Asienga, D., Wagaman, A. S., Purdy, A. E., Rajapakshe, O. B. W.
10.1101/2025.09.15.25335789 — Posted: 2025-09-16
Metabolic Signatures of Pulmonary Embolism in COVID-19: Insights from Longitudinal Intensive Care Unit Profiles
Valdez, M. E., Janssen, M., Zhang, Z., Lamont, L., Singh, M., Yang, W., Nijgh - van Kooij, C., Geerlings, J., Ali, A., Karu, N., de Rijke, Y. B., Harms, A. C., Kindt, A., Gommers, D., Endeman, H., Hankemeier, T.
10.1101/2025.09.12.675971 — Posted: 2025-09-16
Evaluation of Antigen Expression and Early Immune Response following Cutaneous Suction-mediated DNA Delivery
Jhumur, N. C., Um, Y., Park, S. H., Lallow, E. O., Roberts, C. C., Shan, J. W., Singer, J. P., Zahn, J. D., Park, Y. K., Denzin, L. K., Shreiber, D. I., Maslow, J. N., Lin, H.
10.1101/2025.09.15.676388 — Posted: 2025-09-16
An allele-based evolution model of the population spread of SARS-CoV-2
Koopman, J. S., Eisenberg, M. C., Polanco, A., Simon, C. P.
10.1101/2025.09.15.25335781 — Posted: 2025-09-15
"Till How Long Will We Struggle?": A qualitative exploration of the lingering mental toll of COVID-19 on young people in Sudan and Malawi
Mekki, S., Jumbe, S.
10.1101/2025.09.14.25335714 — Posted: 2025-09-15
PDLIM2 Repression: A Common Mechanism in Viral Lung Infection
Gao, F., Chen, Y., Shapiro, S., Xiao, G., Qu, Z.
10.1101/2025.09.12.675949 — Posted: 2025-09-15
High-stability, clamp-free soluble Sarbecovirus spike trimers and their potential for pan-Sarbecovirus vaccine development.
Langer, C., Boo, I., Zakir, T., Mackenzie-Kludas, C., Samuel, J., Fabb, S. A., Lee, C., Center, R. J., Aggarwal, A., Turville, S. G., Pouton, C. W., Subbarao, K., Coulibaly, F., Drummer, H. E., Poumbourios, P.
10.1101/2025.09.14.676173 — Posted: 2025-09-15
GFAP as a Marker of Neuroinflammation in Patients with COVID-19:A Comparative Analysis with Alzheimer's and Parkinson's Disease
Popov, O., Sushentseva, N., Apalko, S., Asinovskaya, A., Mosenko, S., Shcherbak, S., Sarana, A.
10.1101/2025.09.12.25335574 — Posted: 2025-09-14
Pulmonary fibrosis after COVID-19 is characterized by airway abnormalities and elevated club cell secretory protein-16
Baldwin, M. R., Jones, A. E., Zhang, D., Gurung, C., Khan, Z., Saqi, A., Yang, X., Wei, Y., Nandakumar, R., Murphy, S. O., McGroder, C. F., Shaikh, F., Arcasoy, S., Benvenuto, L. J., Grewal, H., Smith, B. M., Yuen, A. Y., Johal, P., Carlsten, C., Ryerson, C., Richards, J. B., Wong, A. W., Nakanishi, T., Shah, A., Garcia, C. K.
10.1101/2025.09.08.25334667 — Posted: 2025-09-12
HAND HYGIENE, COMPLIANCE AND ALCOHOL-BASED PRODUCTS: WHAT WAS THE LEGACY OF THE COVID-19 PANDEMIC?
Coelho de Morais, A. C., dos Santos Saalfeld, S. M., Helbel, C., Marchiotti, M. C., Martinez, H. V., Silva, J. A., Musse, F. C. C., Tognim, M. C. B.
10.1101/2025.09.09.25335069 — Posted: 2025-09-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).